HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Lüftl Selected Research

Matthias Lüftl Research Topics

Disease

3Neoplasms (Cancer)
02/2012 - 08/2004
2Neoplasm Metastasis (Metastasis)
01/2005 - 08/2004
2Melanoma (Melanoma, Malignant)
01/2005 - 08/2004
1Measles
06/2019
1Mumps
06/2019
1Warts (Wart)
06/2019
1Rubella (German Measles)
06/2019
1Paraproteinemias (Monoclonal Gammopathy)
12/2010
1Skin Manifestations
12/2010
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2005
1Acquired Immunodeficiency Syndrome (AIDS)
11/2005
1Disease Progression
08/2004

Drug/Important Bio-Agent (IBA)

2Neoplasm Antigens (Tumor Antigens)IBA
01/2005 - 08/2004
1Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA
06/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
02/2012
1Essential Amino AcidsIBA
02/2012
1EnzymesIBA
02/2012
1Tryptophan (L-Tryptophan)FDA Link
02/2012
1Immunoglobulin M (IgM)IBA
12/2010
1Monoclonal AntibodiesIBA
11/2005
1Rituximab (Mabthera)FDA Link
11/2005
1Messenger RNA (mRNA)IBA
01/2005
1Histocompatibility Antigens Class IIBA
08/2004
1Peptides (Polypeptides)IBA
08/2004

Therapy/Procedure

2Immunotherapy
06/2019 - 01/2005
1Therapeutics
08/2004